Ocuphire Pharma, Inc. (OCUP)
USD 1.17
(-12.03%)
USD 1.17
(-12.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.11 Million | 14.31 Million | -19.37 Million | -6.79 Million | -3.59 Million | -18.93 Million |
| Net Income | -9.98 Million | 17.88 Million | -56.69 Million | -24.62 Million | -6.16 Million | -14.36 Million |
| Depreciation & Amortization | 6000.00 | 4000.00 | 4000.00 | 8000.00 | 3000.00 | 48.21 Thousand |
| Deferred income taxes | 77 Thousand | - | 33.61 Million | -1.49 Million | 499 Thousand | 81.37 Thousand |
| Stock-based compensation | 3.51 Million | 1.8 Million | 1.91 Million | 1.5 Million | 308 Thousand | 177.31 Thousand |
| Change in working capital | 4.07 Million | -5.55 Million | 181 Thousand | 1.14 Million | 357 Thousand | 149.31 Thousand |
| Other non-cash items | 1.2 Million | 170 Thousand | 1.61 Million | 16.66 Million | 1.4 Million | -4.58 Million |
| Investing Cash Flow | - | - | -100 Thousand | 539 Thousand | -25 Thousand | 11.91 Million |
| Investments in PPE | - | - | -100 Thousand | -1.47 Million | -25 Thousand | -39.22 Thousand |
| Acquisitions | - | - | - | 2.01 Million | - | - |
| Investment purchases | - | - | - | - | -8.88 Million | - |
| Sales/Maturities of investments | - | - | - | - | - | 11.95 Million |
| Other Investing Activities | - | - | -100 Thousand | 1.00 | 8.88 Million | 11.91 Million |
| Financing Cash Flow | 8.97 Million | 3.78 Million | 27.6 Million | 21.12 Million | 4.7 Million | 6.87 Million |
| Debt repayment | - | -538 Thousand | -108 Thousand | -2.18 Million | -4.7 Million | - |
| Dividends payments | - | - | - | - | - | -4411.00 |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 8.97 Million | 4.42 Million | 28.49 Million | 21.15 Million | 7.65 Million | 6.87 Million |
| Other Financing Activities | -278 Thousand | -104 Thousand | -778 Thousand | 2.15 Million | 1.75 Million | 1.22 Million |
| Accounts receivables | 2.51 Million | -1.29 Million | - | - | - | - |
| Accounts payables | 1.08 Million | -515 Thousand | 381 Thousand | 792 Thousand | -168 Thousand | -81.37 Thousand |
| Inventory | -1.00 | - | - | - | - | - |
| Other working capital | 477 Thousand | -3.74 Million | -200 Thousand | 354 Thousand | 525 Thousand | 230.69 Thousand |
| Cash at beginning of period | 42.63 Million | 24.53 Million | 16.39 Million | 1.53 Million | 451 Thousand | 8.89 Million |
| Cash at end of period | 50.5 Million | 42.63 Million | 24.53 Million | 16.39 Million | 1.53 Million | 8.74 Million |
| Capital Expenditure | - | - | -100 Thousand | -1.47 Million | -25 Thousand | -39.22 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 7.86 Million | 18.1 Million | 8.13 Million | 14.86 Million | 1.08 Million | -154.85 Thousand |
| Free Cash Flow | -1.11 Million | 14.31 Million | -19.47 Million | -8.27 Million | -3.61 Million | -18.97 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.76 Million | -7.1 Million | -4.79 Million | -9.98 Million | 5.56 Million | -4.96 Million |
| Depreciation & Amortization | - | - | 3000.00 | 6000.00 | 1000.00 | 1000.00 |
| Deferred income taxes | - | - | 8.66 Million | 77 Thousand | 1.73 Million | 445 Thousand |
| Stock-based compensation | 806 Thousand | 985 Thousand | 711 Thousand | 3.51 Million | 573 Thousand | 1.42 Million |
| Change in working capital | -333 Thousand | 395 Thousand | 8.65 Million | 4.07 Million | -10.41 Million | 4.52 Million |
| Other non-cash items | 1.42 Million | 1.86 Million | -8.68 Million | 1.2 Million | -456 Thousand | -445 Thousand |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.54 Million | 2.37 Million | 3.6 Million | 8.97 Million | 5.37 Million | - |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -42 Thousand | - | - | - | - |
| Common Stock Issuance | 1.54 Million | 2.41 Million | 3.6 Million | 8.97 Million | 5.48 Million | - |
| Other Financing Activities | -22 Thousand | -61 Thousand | -172 Thousand | -278 Thousand | -106 Thousand | - |
| Accounts receivables | 812 Thousand | -785 Thousand | 9.01 Million | 2.51 Million | -9.99 Million | 2.69 Million |
| Accounts payables | -1.43 Million | -89 Thousand | 373 Thousand | 1.08 Million | -545 Thousand | 102 Thousand |
| Inventory | - | - | - | -1.00 | - | - |
| Other working capital | 285 Thousand | 1.26 Million | -731 Thousand | 477 Thousand | 126 Thousand | 1.72 Million |
| Cash at beginning of period | 47.16 Million | 50.5 Million | 42.35 Million | 42.63 Million | 39.97 Million | 38.98 Million |
| Cash at end of period | 41.4 Million | 47.16 Million | 50.5 Million | 50.5 Million | 42.35 Million | 39.97 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.75 Million | -3.34 Million | 8.15 Million | 7.86 Million | 2.37 Million | 989 Thousand |
| Free Cash Flow | -7.29 Million | -5.71 Million | 4.54 Million | -1.11 Million | -3 Million | 989 Thousand |
PRME
1530
DNR
603809
TIL
SIHBY